Gene set optimization for cancer transcriptomics using sparse principal component analysis
Frost, H. R.
Show abstract
A common approach for exploring pathway dysregulation in cancer involves the gene set or pathway analysis of tumor transcriptomic data. Unfortunately, the effectiveness of cancer gene set testing is limited by the fact that most gene set collections model gene activity in normal tissue, which can differ significantly from gene activity found within tumors. To address this challenge, we have developed a bioinformatics approach based on sparse principal component analysis (PCA) for optimizing existing gene set collections to reflect the pattern of gene activity in dysplastic tissue and have used this technique to optimize the Molecular Signatures Database (MSigDB) Hallmark collection for 21 solid human cancers profiled via bulk RNA-seq by The Tumor Genome Atlas (TCGA). Demonstrating the biological utility of our approach, the average survival association of gene set members is improved after optimization for nearly all cancer types and Hallmark gene sets.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- New analysis framework incorporating mixed mutual information and scalable Bayesian networks for multimodal high dimensional genomic and epigenomic cancer data 95%
- A Network-centric Framework for theEvaluation of Mutual Exclusivity Tests onCancer Drivers 94%
- Cancer as a tissue anomaly: classifying tumor transcriptomes based only on healthy data 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.